Log In
BCIQ
Print this Print this
 

OTSGC-A24

  Manage Alerts
Collapse Summary General Information
Company OncoTherapy Science Inc.
DescriptionHLA-restricted cancer vaccine cocktail targeting specific tumor antigens FOXM1, DEPDC1, KIF20A, URLC10 and VEGFR-1
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationGastric cancer
Indication DetailsTreat gastric cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today